3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
19
Recurrence
5
Sarcoma, Kaposi
2
Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Plasmacytoma
1
Plasmablastic Lymphoma
1
Neoplasms, Plasma Cell
1
Multi-centric Castleman's Disease
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Epstein-Barr Virus Infections
1
Burkitt Lymphoma
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Cyclophosphamide
4
pembrolizumab
3
fludarabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
atezolizumab
2
anlotinib
2
Temozolomide
2
Irinotecan
2
Ifosfamide
2
Carboplatin
2
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
talazoparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
pomalidomide
×
30 days
×
Clear all
No trials found.